Type 1 Diabetes (original) (raw)
Latest News for: type 1 diabetes
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes (Sanofi SA)
Public Technologies 13 Jun 2026
). The text version of this document is not available ... Attachments Permalink. Disclaimer.
US FDA approves expanded use of Sanofi's type 1 diabetes drug
Business Line 13 Jun 2026
Sanofi’s type 1 diabetes ...
Breakthrough T1D Celebrates Approval of Tzield for use in Stage 3 Type 1 Diabetes in ...
Rocky Mount Telegram 13 Jun 2026
NEW YORK, June 12, 2026 /PRNewswire/ -- Breakthrough ...
US FDA approves expanded use of Sanofi’s type 1 diabetes drug in children aged 8 ...
Straits Times 13 Jun 2026
However, the drug, Tzield, has also been under FDA scrutiny over safety concerns ....
Breakthrough T1D Celebrates Approval of Tzield for use in Stage 3 Type 1 Diabetes in the US
PR Newswire 13 Jun 2026
About Breakthrough T1D, Formerly JDRFAs the leading global type 1 diabetes research and advocacy organization, Breakthrough T1D helps make everyday life with type 1 diabetes better while driving toward cures.
Eli Lilly's Foundayo Tops Oral Semaglutide On Key Measures In Type 2 Diabetes Trial
NDTV 10 Jun 2026
Over 52 weeks, the Achieve-3 study compared two doses of Foundayo with approved oral semaglutide doses in 1,698 people with type 2 diabetes who were not adequately controlled on metformin ... .
Type 2 Diabetes Market to Value USD 85 Billion by 2035, Growing at a 7.69% ...
Nasdaq Globe Newswire 10 Jun 2026
... as Advanced Cardiometabolic Therapies Transform Diabetes Care.
Pancreas-Targeted GLP-1Gene Therapy Enhances β-Cell Function and Reduces Cellular Stress in Preclinical Type 2 Diabetes Models (Fractyl Health Inc)
Public Technologies 10 Jun 2026
). The text version of this document is not available ... Attachments Permalink. Disclaimer.
Syntax Bio Announces Collaboration with Mayo Clinic to Advance Pancreatic Cell Therapy for Type 1 Diabetes
The Joplin Globe 09 Jun 2026
CHICAGO--(BUSINESS WIRE)--Jun 9, 2026-- ... .
Ercros supports the Valenta Sugar Cup in aid of type 1 diabetes research (Ercros SA)
Public Technologies 09 Jun 2026
With this collaboration, Ercros participates for the third consecutive year in this initiative and contributes to promoting type 1 diabetes research and raising awareness in society about the impact of this disease.
Novo Nordisk introduces updated Rybelsus® tablet formulation in Canada for adults living with type 2 diabetes
Canada Newswire 09 Jun 2026
Rybelsus® (semaglutide tablets) is the first and only GLP-1 tablet approved in Canada for adults with type 2 diabetes.1 The updated formulation offers the same established clinical profile at lower ...
Alexander Zverev triumphs at Roland Garros despite Type 1 Diabetes
Gulf News 08 Jun 2026
... was up against two opponents, Italian Flavio Cobolli and Type 1 Diabetes.
Living With Type 1 Diabetes Since Age 4, Alexander Zverev Wins First Grand Slam At 29
News18 08 Jun 2026
The French Open champion has spent 25 years managing Type 1 diabetes, proving the condition does not have to limit ambition ....
CrowdHealth Unveils Bold New Program to Reverse Type 2 Diabetes
PR Newswire 08 Jun 2026
AUSTIN, Texas, June 8, 2026 /PRNewswire/ -- CrowdHealth today announced the launch of a revolutionary new program aimed at helping participants reverse Type 2 Diabetes.
New study shows promising functional cure for Type 1 diabetes
WPXI 08 Jun 2026
It’s a development millions of people living with Type 1 diabetes never thought would happen ... Type 1 diabetes is an autoimmune condition where the body’s immune system destroys the insulin-producing cells in the pancreas.